RiiSE20 Conference Apr 04, 2020 08:30 AM - 05:00 PM — Chancellor’s Building, Edinburgh BioQuarter
Scottish Clinical Imaging Network (SCIN) Annual Event 2020 Apr 30, 2020 09:00 AM - 04:00 PM — Glasgow Caledonian University
NCITA National Conference: Translating Imaging Biomarkers for Improved Patient Outcomes May 05, 2020 10:00 AM - 05:00 PM — New Hunt's House, Guy's Campus, King's College London
Scottish Radiological Society Spring Meeting 2020 May 15, 2020 09:00 AM - 04:10 PM — Centre for Health Science, Inverness
2020 SINAPSE ASM Jun 18, 2020 - Jun 19, 2020 — Medical Sciences Building, University of St Andrews

eLearning

SINAPSE experts from around Scotland have developed ten online modules designed to explain medical imaging. They are freely available and are intended for non-specialists.


Edinburgh Imaging Academy at the University of Edinburgh offers the following online programmes through a virtual learning environment:

Neuroimaging for Research MSc/Dip/Cert

Imaging MSc/Dip/Cert

PET-MR Principles & Applications Cert

Applied Medical Image Analysis Cert

Online Short Courses

People

Your search for Keyword: 'Novel Radiotracers' returned 6 Result(s)

Enter search terms to filter list of SINAPSE members

Search across research interests, themes, institutions, and publication titles



Dr Sue Champion

I am a Radiochemist with experience in both SPECT and PET chemistry. Before I came to Glasgow, I worked for many years as both a radiochemist and a synthetic chemist in the radiopharmaceutical industry. My interests are using radiotracers to look at changes in biological chemistry in disease. As such, I’m interested in the development of novel radiotracers, which is a multi-disciplinary process bringing together chemistry, radiochemistry and biology, and the translation of such new tracers from a pre-clinical phase into the clinic. I’m also interested in the clinical applications of new and existing radiotracers, in which I collaborate with colleagues in Clinical Physics and Psychological Medicine. Beyond the development and use of tracers, I’m interested in the development of radiolabelling and purification methods

Full profile…


Miss MariaClara Liuzzi

Cancer research and development, drug discovery of antitumoral agents, targeted therapies, molecular imaging as innovative tool of diagnosis and treatment of brain tumours, medicinal chemistry of PARP inhibitors, radiochemistry, pre-clinical studies.

Full profile…


Dr Gaurav Malviya

Involved in basic and clinical research in the study of the host response to cancer.

Full profile…


Dr Jonathan Owens


Full profile…


Dr Sally Pimlott

Dr Pimlott is the principal radiochemist in the research and development radiopharmaceutical group, based at the Radionuclide Dispensary, Western Infirmary, Glasgow. Her research is focused on the development of novel molecular imaging agents. This includes:-

  • the development of novel radiolabelling methodologies
  • the synthesis and evaluation of novel tracer candidates using both in vitro and in vivo imaging techniques
  • the development of novel in vitro methodologies for the prediction of radiotracer in vivo characteristics.

Dr Pimlott is also experienced in the provision of radiopharmaceuticals for clinical research studies in compliance with Good Manufacturing Practice standards. Research is funded by the SINAPSE, Wellbeing of Women, Translational Medicine Research Collaboration (TMRC), Neurosciences Foundation, Chief Scientist Office (Scottish Executive), Medical Research Scotland and GE Healthcare.

Full profile…


Dr Dmitry Soloviev


Full profile…